Alveolar type II cells harbouring SARS-CoV-2 show senescence with a proinflammatory phenotype
K. Paschalaki (London, United Kingdom), K. Evangelou (Athens, Greece), D. Veroutis (Athens, Greece), P. Foukas (Athens, Greece), C. Kittas (Athens, Greece), A. Tzioufas (Athens, Greece), L. De Leval (Lausanne, Switzerland), D. Vassilakos (Athens, Greece), P. Barnes (London, United Kingdom), V. Gorgoulis (Athens, Greece)
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Paschalaki (London, United Kingdom), K. Evangelou (Athens, Greece), D. Veroutis (Athens, Greece), P. Foukas (Athens, Greece), C. Kittas (Athens, Greece), A. Tzioufas (Athens, Greece), L. De Leval (Lausanne, Switzerland), D. Vassilakos (Athens, Greece), P. Barnes (London, United Kingdom), V. Gorgoulis (Athens, Greece). Alveolar type II cells harbouring SARS-CoV-2 show senescence with a proinflammatory phenotype. 4312
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: